578 related articles for article (PubMed ID: 22627188)
21. [Epithelial-mesenchymal transition in cancer progression].
Gos M; Miłoszewska J; Przybyszewska M
Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
[TBL] [Abstract][Full Text] [Related]
22. Inflammation and cancer stem cells.
Shigdar S; Li Y; Bhattacharya S; O'Connor M; Pu C; Lin J; Wang T; Xiang D; Kong L; Wei MQ; Zhu Y; Zhou S; Duan W
Cancer Lett; 2014 Apr; 345(2):271-8. PubMed ID: 23941828
[TBL] [Abstract][Full Text] [Related]
23. PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression.
Fischer AN; Fuchs E; Mikula M; Huber H; Beug H; Mikulits W
Oncogene; 2007 May; 26(23):3395-405. PubMed ID: 17130832
[TBL] [Abstract][Full Text] [Related]
24. [TGF-β signaling pathways in cancers].
Talar B; Czyż M
Postepy Hig Med Dosw (Online); 2013 Sep; 67():1008-17. PubMed ID: 24088545
[TBL] [Abstract][Full Text] [Related]
25. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
Labelle M; Schnittler HJ; Aust DE; Friedrich K; Baretton G; Vestweber D; Breier G
Cancer Res; 2008 Mar; 68(5):1388-97. PubMed ID: 18316602
[TBL] [Abstract][Full Text] [Related]
27. TGF-β-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells.
Kawata M; Koinuma D; Ogami T; Umezawa K; Iwata C; Watabe T; Miyazono K
J Biochem; 2012 Feb; 151(2):205-16. PubMed ID: 22161143
[TBL] [Abstract][Full Text] [Related]
28. Occurrence and significance of epithelial-mesenchymal transition in breast cancer.
Roxanis I
J Clin Pathol; 2013 Jun; 66(6):517-21. PubMed ID: 23322823
[TBL] [Abstract][Full Text] [Related]
29. Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system.
Karlsson MC; Gonzalez SF; Welin J; Fuxe J
Mol Oncol; 2017 Jul; 11(7):781-791. PubMed ID: 28590032
[TBL] [Abstract][Full Text] [Related]
30. Inflammation linking EMT and cancer stem cells.
Zhou C; Liu J; Tang Y; Liang X
Oral Oncol; 2012 Nov; 48(11):1068-75. PubMed ID: 22766510
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional crosstalk between TGF-β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes.
Fuxe J; Vincent T; Garcia de Herreros A
Cell Cycle; 2010 Jun; 9(12):2363-74. PubMed ID: 20519943
[TBL] [Abstract][Full Text] [Related]
32. The role of small GTPases of the Rho/Rac family in TGF-β-induced EMT and cell motility in cancer.
Ungefroren H; Witte D; Lehnert H
Dev Dyn; 2018 Mar; 247(3):451-461. PubMed ID: 28390160
[TBL] [Abstract][Full Text] [Related]
33. TGF-beta in CAF-mediated tumor growth and metastasis.
Calon A; Tauriello DV; Batlle E
Semin Cancer Biol; 2014 Apr; 25():15-22. PubMed ID: 24412104
[TBL] [Abstract][Full Text] [Related]
34. Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.
Dominguez C; David JM; Palena C
Semin Cancer Biol; 2017 Dec; 47():177-184. PubMed ID: 28823497
[TBL] [Abstract][Full Text] [Related]
35. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
Chockley PJ; Keshamouni VG
J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
[TBL] [Abstract][Full Text] [Related]
36. [The role of TGF-beta in the EMT of tumor cells].
Liu DZ; Wang YS; Ji AG
Sheng Li Ke Xue Jin Zhan; 2011 Dec; 42(6):463-6. PubMed ID: 22363989
[No Abstract] [Full Text] [Related]
37. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
Hao Y; Baker D; Ten Dijke P
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195692
[TBL] [Abstract][Full Text] [Related]
38. The fundamental role of mechanical properties in the progression of cancer disease and inflammation.
Mierke CT
Rep Prog Phys; 2014 Jul; 77(7):076602. PubMed ID: 25006689
[TBL] [Abstract][Full Text] [Related]
39. TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives.
Dituri F; Mancarella S; Cigliano A; Chieti A; Giannelli G
Semin Liver Dis; 2019 Feb; 39(1):53-69. PubMed ID: 30586675
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-β as a therapeutic target in hepatocellular carcinoma.
Giannelli G; Villa E; Lahn M
Cancer Res; 2014 Apr; 74(7):1890-4. PubMed ID: 24638984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
